Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Treatment of Primary CNS Lymphoma with Induction High-Dose Methotrexate, Temozolomide, Rituximab Followed by Consolidation Cytarabine/Etoposide: A Pilot Study with Biomarker Analysis.

Samar Issa, MD, Arthur Shen, B.S., Jon Karch, B.S., Cigall Kadoch, B.S., Marc Shuman, M.D., Lloyd Damon, M.D., James Rubenstein, MD, PhD

Blood (2007) 110 (11): 1364.

https://doi.org/10.1182/blood.V110.11.1364.1364

Published: 2007

Journal Articles

Identification of CSF Biomarkers for the Diagnosis of CNS Lymphoma.

James L. Rubenstein, MD, PhD, Cigall Kadoch, Jon Karch, BA, Andrew Josephson, MD, Samar Issa, MD, Chris Becker, PhD, Howard Schulman, PhD, Lloyd Damon, MD, Marc A. Shuman, MD, Sushmita Roy, PhD

Blood (2006) 108 (11): 2036.

https://doi.org/10.1182/blood.V108.11.2036.2036

Published: 2006

Journal Articles

Voriconazole Is Safe and Effective as Prophylactic Antifungal Therapy Following Allogeneic Transplantation.

Thomas Martin, MD, Meaghan Working, Ryan O’Malley, Joe Guglielmo, Neal Fischbach, MD, Lloyd Damon, MD, Willis Navarro, MD, Lawry Kaplan, MD, Richard Jacobs, John Andrews, Charles Linker, MD

Blood (2004) 104 (11): 5094.

https://doi.org/10.1182/blood.V104.11.5094.5094

Published: 2004

Journal Articles

Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report.

Lloyd Damon, Donna Niedzwiecki, Jeff Johnson, Bruce Cheson, David Hurd, Nancy Barlett, Michael Kelly, Charles Linker, George Canellos

Blood (2004) 104 (11): 895.

https://doi.org/10.1182/blood.V104.11.895.895

Published: 2004

Journal Articles

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

James L. Rubenstein, Dan Combs, Jay Rosenberg, Arthur Levy, Michael McDermott, Lloyd Damon, Robert Ignoffo, Kenneth Aldape, Arthur Shen, Dana Lee, Antonio Grillo-Lopez, Marc A. Shuman

Blood (2003) 101 (2): 466–468.

https://doi.org/10.1182/blood-2002-06-1636

Published: 2003

NARROW

Treatment of Primary CNS Lymphoma with Induction High-Dose Methotrexate, Temozolomide, Rituximab Followed by Consolidation Cytarabine/Etoposide: A Pilot Study with Biomarker Analysis.

Identification of CSF Biomarkers for the Diagnosis of CNS Lymphoma.

Voriconazole Is Safe and Effective as Prophylactic Antifungal Therapy Following Allogeneic Transplantation.

Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report.

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

Email alerts

ASH Publications

American Society of Hematology

Treatment of Primary CNS Lymphoma with Induction High-Dose Methotrexate, Temozolomide, Rituximab Followed by Consolidation Cytarabine/Etoposide: A Pilot Study with Biomarker Analysis.

Identification of CSF Biomarkers for the Diagnosis of CNS Lymphoma.

Voriconazole Is Safe and Effective as Prophylactic Antifungal Therapy Following Allogeneic Transplantation.

Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report.

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only